Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
3.040
-0.010 (-0.33%)
At close: Mar 3, 2026, 4:00 PM EST
3.040
0.00 (0.00%)
After-hours: Mar 3, 2026, 4:53 PM EST
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
Identifying and Developing Tnnovative Therapies | 7.83M | 18.72M | - | - | - | | | | | |
Identifying and Developing Tnnovative Therapies Growth | -58.19% | - | - | - | - | | | | | |
| - | - | 19.58M | 17.01M | 13.45M | | | | | |
| - | - | 15.13% | 26.46% | 0.96% | | | | | |
| - | - | 28.21M | 25.36M | 932.00K | | | | | |
| - | - | 11.27% | 2620.60% | 33.91% | | | | | |
| - | - | -16.54M | -12.61M | -7.62M | | | | | |
| 7.83M | 18.72M | 31.25M | 29.75M | 6.76M | | | | | |
| -58.19% | -40.09% | 5.03% | 340.05% | 4.30% | | | | | |
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| 7.83M | 18.72M | 31.25M | 29.75M | 6.76M | | | | | |
| -58.19% | -40.09% | 5.03% | 340.05% | 4.30% | | | | | |
| 7.83M | 18.72M | 31.25M | 29.75M | 6.76M | | | | | |
| -58.19% | -40.09% | 5.03% | 340.05% | 4.30% | | | | | |
Source: S&P Global Market Intelligence.
